United Kingdom · 
Who invested in Chronos Therapeutics?
Chronos Therapeutics's investors include University of Oxford, Odey Asset Management, TESTUDO Fund and Odey Swan.
United Kingdom · Funded startup
Who invested in Chronos Therapeutics
Funding summaryUpdated 26 Oct 2026
$12Mraised across 1 round since 2013, from 1 source
- Latest round
- Round, $12MDec 2013
- Investors
- 4
The rounds
- Dec 2013
Founders and team
From Chronos Therapeutics's own website: 5 on the team.
- Dr Glen ClackChief Medical Officer
- Dr Helen KuhlmanChief Operating Officer
- Dr Alan BargeNon-executive Director
- Dr Alastair SmithNon-executive Chair
- Edward WardleNon-executive Director
Everyone who backed them
Odey Swanno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Chronos Therapeutics
How much has Chronos Therapeutics raised?
Chronos Therapeutics has raised $12M across 1 round since 2013.
When did Chronos Therapeutics last raise?
Chronos Therapeutics's most recent round was an Undisclosed round of $12M in Dec 2013.
What was Chronos Therapeutics's biggest round?
Its most recent round, $12M in Dec 2013, is also its largest on record.
Who backed Chronos Therapeutics first?
Chronos Therapeutics's first round on record, in Dec 2013, was backed by University of Oxford, Odey Asset Management and TESTUDO Fund and 1 others.
What stage is Chronos Therapeutics at?
Chronos Therapeutics's latest named round is an Undisclosed round, in Dec 2013.
Where is Chronos Therapeutics based?
Chronos Therapeutics is based in the United Kingdom.
Companies like Chronos Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.